ACN (ACN) insider files to sell 500 Class A Ordinary shares

Rhea-AI Filing Summary

A holder of 500 Class A Ordinary shares has filed notice to sell these securities of issuer ACN through UBS Financial Services, Inc. on the NYSE. The planned sale has an aggregate market value of 140000.00 and is referenced against 660,432,542 shares outstanding.

The seller acquired the 500 shares on 10/20/2025 as a stock award from the issuer, with the same date listed as the payment date and the nature of payment marked as “N/A,” indicating no separate cash purchase. The approximate proposed sale date is 01/07/2026. The form also includes a representation that the seller is not aware of undisclosed material adverse information about the issuer’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Ordinary	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	500	140000.00	660432542	01/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Ordinary	10/20/2025	Stock Award	Issuer			500	10/20/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for ACN disclose?

The Form 144 discloses an intended sale of 500 Class A Ordinary shares of issuer ACN, to be sold through UBS Financial Services, Inc. on the NYSE.

How many ACN shares are planned to be sold under this Form 144?

The filing covers a proposed sale of 500 Class A Ordinary shares of ACN.

What is the aggregate market value of the ACN shares to be sold?

The 500 Class A Ordinary shares have an aggregate market value of 140000.00 according to the filing.

When were the ACN shares to be sold acquired and how?

The 500 Class A Ordinary shares were acquired on 10/20/2025 as a stock award from the issuer, with no separate cash payment indicated.

When is the approximate sale date for the ACN shares in this Form 144?

The approximate date of sale listed for the 500 Class A Ordinary shares is 01/07/2026.

How many ACN shares are outstanding according to this filing?

The table in the filing lists 660,432,542 shares of the relevant class as outstanding.